Q3 2025
-
Tenet Announces Q3 2025 Financial Results
words.Tenet Fintech Group (OTC: PKKFF) posted Q3‑2025 revenue of $237,350 and a net loss of $3.585 M, with operating cash flow of –$5.77 M (CAD). The company upgraded Cubeler’s Networking and Insights modules, refreshed the Cubeler.com site, and launched an AI‑driven data‑standardization tool for SME accounting. It also signed a new corporate‑seal custodian agreement for its Chinese subsidiary with Jiangsu Shenque Law Firm. A CEO Q&A on the results will be released on December 5, 2025.
-
Vivoryon Therapeutics N.V. Announces Q3 2025 Financial Results and Operational Update on December 4, 2025
Vivoryon Therapeutics (VVY) will release its Q3 2025 financial results and operational progress on December 4, 2025. A conference call and webcast will be held at 3:00 pm CET / 9:00 am EST. The webcast will be available on Vivoryon’s investor relations site. Participants planning to dial in are encouraged to pre-register for expedited access and to call in 15 minutes early. The company will provide an update on its varoglutamstat program for diabetic kidney disease.
-
First International Bank of Israel Announces Q3 2025 Financial Results
FIBI announced its Q3 2025 financial results, demonstrating growth and profitability. Net income for the first nine months reached NIS 1,748 million (ROE 16.9%). Q3 net income was NIS 581 million (ROE 16.2%), impacted by nonrecurring losses at CAL. Revenue increased by 6% year-over-year for the first nine months. Customer assets grew by 34.4% to NIS 1.074 trillion. The Board approved a dividend distribution of NIS 436 million. CEO Eli Cohen highlighted FIBI’s resilience and loan portfolio quality.
-
Zeekr Group Announces Q3 2025 Unaudited Financial Results
ZEEKR Intelligent Technology (ZK) announced its Q3 2025 financial results. Vehicle deliveries totaled 140,195 units, a 12.5% YoY increase. Zeekr brand delivered 52,860 vehicles, and Lynk & Co reported 87,335 vehicles delivered (NEV portion was 72.4%). Vehicle sales reached RMB26,527 million, up 7.3% YoY. The vehicle margin was 15.6%. Total revenues increased to RMB31,562 million, a 9.1% YoY increase. Gross profit also rose to RMB6,046 million, a 37.1% YoY increase.
-
Discovery Reports Q3 2025 Gold Production of 63,154 Ounces and $86.8 Million Free Cash Flow
Discovery (DSVSF) reported strong Q3 2025 results, boosted by the Porcupine Complex acquisition. Gold production reached 63,154 ounces, generating $237.0M in revenue and $42.4M net earnings ($0.05/share). Operating cash flow was $153.5M, yielding $86.8M in free cash flow. The company’s cash position strengthened to $341.5M. A new $250M revolving credit facility provides further liquidity. However, the average gold grade decreased, and shares outstanding significantly increased due to share issuance. Exploration results were encouraging.
-
Zedcor Inc. Announces Q3 2025 Results: $16.0 Million Revenue and $5.7 Million Adjusted EBITDA
Zedcor (ZDCAF) reported record Q3 2025 results, with $16.0 million in revenue (+75% YoY) and $5.7 million in Adjusted EBITDA (+68% YoY). The Adjusted EBITDA margin was 36%. Zedcor’s fleet reached 2,351 units (1,053 in the U.S.). The company raised $25.311 million in equity and increased its banking facility to $50.0 million. U.S. revenue was 36% of Q3 revenue, with Houston production at 35–40 towers/week. However, they reported a working capital deficit of $(4.8)M.
-
PyroGenesis Announces Third Quarter 2025 Results
PyroGenesis reported Q3 2025 revenue of $3.25M, down 18.7% YoY, with a 24% gross margin. Net loss was $2.25M, and modified EBITDA loss was $1.89M. Backlog stands at $51.6M (81% USD). Key wins include a Constellium contract, a $1.2M cement sector deal, and a titanium powder order. Fumed silica pilot results showed improved surface area (136 m²/g) and 0% carbon. Post-quarter, >$5M was raised, including CEO participation. The company is focused on innovation and a strong finish to 2025.
-
Integrated BioPharma Announces Results for Quarter Ended September 30, 2025
Integrated BioPharma (INBP) reported its Q3 2025 financial results, revealing a 6.6% revenue decrease to $12.7 million compared to Q3 2024. Gross profit, operating income, and net income also declined. A significant concern is the high customer concentration, with the top two clients accounting for approximately 87% of revenue, up from 85% in the prior year. Despite decreased revenue and profits, INBP still maintained a net income of $0.12 million, or $0.00 diluted per share.
-
BIO-key to Host Q3 Investor Call on November 14th
BIO-key International (BKYI) will release its Q3 2025 results before market open on November 14, 2025, followed by an investor call at 10:00 a.m. ET. CEO Mike DePasquale and CFO Cecilia Welch will lead the call, discussing company performance and strategic initiatives. A live webcast and replay will be available to investors. The call will include a Q&A session, and the webcast replay will be accessible for three months. Dial-in details are provided for both U.S. and international participants.
-
Willdan Group Q3 Earnings Announcement
Willdan Group (WLDN) reported strong Q3 2025 financial results, with contract revenue up 15% to $182.0 million and net revenue increasing 25.5% to $95.0 million. Net income surged 86.8% to $13.7 million, and adjusted EBITDA rose 52.5% to $23.1 million. The company is raising its full-year 2025 financial targets, now anticipating net revenue between $360 million and $365 million and adjusted diluted EPS between $4.10 and $4.20. Willdan attributes its success to data center infrastructure and electrification initiatives.